SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Izzy who wrote (2742)11/12/1997 9:14:00 PM
From: Oliver & Co   of 6136
 
I am very upset too. I am still holding the 47 1/2 for Nov calls. But that is the market. There are some people making a mint on AGPH, the traders. The spread between the bid and ask, has been almost a dollar. I think that this is all just the market. Look at the volume.

BTW the Agouron Advisory Panel is this Saturday AM. My BIG question will not be Viracept(I know just how good it is), or even Thymitaq?, it will be the cold spray. That is where the BIG MONEY is in this company. The day that comes out the stock will go up over $1000, then I will sell my shares.

Their next HIV product will be an Integrase Inhibitor (the NIH asked them for it), likely not another PI.

JLL
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext